[Form 4] Research Solutions, Inc. Insider Trading Activity
William Nurthen, Chief Financial Officer and Secretary of Research Solutions, Inc. (RSSS), reported a transaction dated 09/19/2025 in which he surrendered 2,225 shares of the company’s common stock to the issuer to cover taxes on vested restricted stock at an effective price of $3.66 per share. After the surrender, he beneficially owned 378,382 shares. The filing is signed by Mr. Nurthen on 09/26/2025. The explanation states the share surrender was approved by the Compensation Committee.
William Nurthen, Direttore Finanziario e Segretario di Research Solutions, Inc. (RSSS), ha riportato una operazione datata 19/09/2025 con la quale ha ceduto 2.225 azioni ordinarie della società all'emittente per coprire le tasse sulle azioni vincolate maturate, a un prezzo effettivo di $3,66 per azione. Dopo la cessione, detiene beneficialmente 378.382 azioni. La dichiarazione è stata firmata dal sig. Nurthen il 26/09/2025. L'esposizione indica che la cessione delle azioni è stata approvata dal Compensation Committee.
William Nurthen, Director de Finanzas y Secretario de Research Solutions, Inc. (RSSS), informó una operación con fecha 19/09/2025 en la que entregó 2.225 acciones ordinarias de la empresa al emisor para cubrir impuestos sobre acciones restringidas que se han adquirudo, a un precio efectivo de $3,66 por acción. Tras la entrega, posee de forma beneficiosa 378.382 acciones. La presentación está firmada por el Sr. Nurthen el 26/09/2025. La explicación indica que la entrega de las acciones fue aprobada por el Comité de Compensación.
리서치 솔루션스, Inc. (RSSS)의 최고재무책임자이자 비서인 윌리엄 누르덴은 2025/09/19자로 공시된 거래를 보고했고, 회사의 보통주 2,225주를 발행사에 양도하여 취득한 제한주식의 세금을 커버하기 위해 매도했으며, 주당 실효가격은 $3.66 달러였습니다. 양도 후 그는 유익하게 378,382주를 보유하게 되었습니다. 이 서류는 2025/09/26에 누르덴 씨가 서명했습니다. 설명에 따르면 주식 양도는 보상위원회에서 승인되었습니다.
William Nurthen, directeur financier et secrétaire de Research Solutions, Inc. (RSSS), a déclaré une opération datée du 19/09/2025 au cours de laquelle il a cédé 2 225 actions ordinaires de la société à l’émetteur pour couvrir les impôts sur les actions restreintes acquises, à un prix effectif de $3,66 par action. Après cette cession, il détient bénéficamente 378 382 actions. Le document est signé par M. Nurthen le 26/09/2025. L’explication indique que la cession d’actions a été approuvée par le Comité de rémunération.
William Nurthen, Chief Financial Officer und Secretary von Research Solutions, Inc. (RSSS), meldete eine Transaktion vom 19.09.2025, bei der er 2.225 Stammaktien des Unternehmens an den Emittenten abgab, um Steuern auf vestete Restricted Stock zu decken, zu einem effektiven Preis von $3,66 pro Aktie. Nach der Abgabe hielt er wirtschaftlich 378.382 Aktien. Die Einreichung wurde von Herrn Nurthen am 26.09.2025 unterschrieben. Die Erklärung besagt, dass die Aktienabgabe vom Compensation Committee genehmigt wurde.
أفاد وليام نورتن، المدير المالي التنفيذي وأمين Research Solutions, Inc. (RSSS)، عن عملية تاريخها 19/09/2025 قام فيها بالتخلي عن 2,225 سهماً عادياً من أسهم الشركة إلى المصدر لتغطية ضرائب الأسهم المقيدة الممنوحة عند سعر فعال قدره $3.66 للسهم. بعد التخلي، أصبح يملك بشكل فعّال 378,382 سهماً. تم توقيع الإفادة من قبل السيد نورتن في 26/09/2025. وتذكر الشرح أن التخلي عن الأسهم قد تمت الموافقة عليه من قبل لجنة التعويضات.
William Nurthen,Research Solutions, Inc.(RSSS)的首席财务官兼秘书,报告了一笔日期为 2025/09/19 的交易,他向发行方转让了 2,225 股公司普通股以用于支付已归属受限股票的税款,实际价格为每股 $3.66。转让后,他实际持有 378,382 股。该披露由 Nurthen 先生在 2025/09/26 签署。说明称这笔股票让渡已获薪酬委员会批准。
- None.
- None.
Insights
TL;DR: Routine tax-withholding surrender of vested restricted stock by the CFO, approved by the Compensation Committee; not evidently material.
This Form 4 documents a common administrative transaction where an executive surrenders shares to cover tax obligations on vested restricted stock. The quantity surrendered (2,225 shares) represents a small fraction of the post-transaction beneficial ownership (378,382 shares), indicating no meaningful change in ownership stake or control. The Compensation Committee approval and timely reporting demonstrate adherence to governance and reporting procedures.
TL;DR: Transaction is a non-sale tax withholding event by an insider, producing no clear positive or negative signal for investors.
The filing shows the transaction code consistent with surrender to cover taxes rather than an open-market sale. The per-share price reported ($3.66) is an accounting reference for the withholding; it should not be interpreted as a discretionary liquidity event. Given the small size relative to total holdings and absence of additional sales or derivative activity, this disclosure is routine and unlikely to have market impact.
William Nurthen, Direttore Finanziario e Segretario di Research Solutions, Inc. (RSSS), ha riportato una operazione datata 19/09/2025 con la quale ha ceduto 2.225 azioni ordinarie della società all'emittente per coprire le tasse sulle azioni vincolate maturate, a un prezzo effettivo di $3,66 per azione. Dopo la cessione, detiene beneficialmente 378.382 azioni. La dichiarazione è stata firmata dal sig. Nurthen il 26/09/2025. L'esposizione indica che la cessione delle azioni è stata approvata dal Compensation Committee.
William Nurthen, Director de Finanzas y Secretario de Research Solutions, Inc. (RSSS), informó una operación con fecha 19/09/2025 en la que entregó 2.225 acciones ordinarias de la empresa al emisor para cubrir impuestos sobre acciones restringidas que se han adquirudo, a un precio efectivo de $3,66 por acción. Tras la entrega, posee de forma beneficiosa 378.382 acciones. La presentación está firmada por el Sr. Nurthen el 26/09/2025. La explicación indica que la entrega de las acciones fue aprobada por el Comité de Compensación.
리서치 솔루션스, Inc. (RSSS)의 최고재무책임자이자 비서인 윌리엄 누르덴은 2025/09/19자로 공시된 거래를 보고했고, 회사의 보통주 2,225주를 발행사에 양도하여 취득한 제한주식의 세금을 커버하기 위해 매도했으며, 주당 실효가격은 $3.66 달러였습니다. 양도 후 그는 유익하게 378,382주를 보유하게 되었습니다. 이 서류는 2025/09/26에 누르덴 씨가 서명했습니다. 설명에 따르면 주식 양도는 보상위원회에서 승인되었습니다.
William Nurthen, directeur financier et secrétaire de Research Solutions, Inc. (RSSS), a déclaré une opération datée du 19/09/2025 au cours de laquelle il a cédé 2 225 actions ordinaires de la société à l’émetteur pour couvrir les impôts sur les actions restreintes acquises, à un prix effectif de $3,66 par action. Après cette cession, il détient bénéficamente 378 382 actions. Le document est signé par M. Nurthen le 26/09/2025. L’explication indique que la cession d’actions a été approuvée par le Comité de rémunération.
William Nurthen, Chief Financial Officer und Secretary von Research Solutions, Inc. (RSSS), meldete eine Transaktion vom 19.09.2025, bei der er 2.225 Stammaktien des Unternehmens an den Emittenten abgab, um Steuern auf vestete Restricted Stock zu decken, zu einem effektiven Preis von $3,66 pro Aktie. Nach der Abgabe hielt er wirtschaftlich 378.382 Aktien. Die Einreichung wurde von Herrn Nurthen am 26.09.2025 unterschrieben. Die Erklärung besagt, dass die Aktienabgabe vom Compensation Committee genehmigt wurde.